Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07758127

Updates and Insights on HER2 in Breast Cancer in Sohag Governorate

Sponsor: Sohag University

View on ClinicalTrials.gov

Summary

* To evaluate HER2 expression in breast carcinoma with emphasizing HER2-ultralow, and HER2-low, HER2 equivocal tumors. * To correlate the results of HER2 with clinico-pathological prognostic parameters; examples tumor grade, Ki-67 proliferation index, nodal status, tumor size, lympho-vascular invasion, and perineural invasion, tumor infiltrating lymphocytes * To access interobserval agreement in HER2 score interpretation

Official title: Updates and Insights on Human Epidermal Growth Factor Receptor 2 (HER2) in Breast Cancer in Sohag Governorate

Key Details

Gender

FEMALE

Age Range

26 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2026-09

Completion Date

2027-12

Last Updated

2026-08-11

Healthy Volunteers

No

Locations (1)

Faculty of medicine sohag university

Sohag, Egypt